⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL115533 | 1.00 | — | — | |
| SCHEMBL681519 | 1.00 | — | — | |
| SCHEMBL6718961 | 0.96 | — | — | |
| SCHEMBL10729300 | 0.96 | — | — | |
| SCHEMBL3116714 | 0.96 | — | — | |
| SCHEMBL8699529 | 0.87 | — | — | |
| SCHEMBL11689836 | 0.83 | TSHR (0.30) | — | |
| Thiocyanic Acid SCHEMBL9214638 | 0.83 | — | — | |
| SCHEMBL1821872 | 0.79 | — | — | |
| SCHEMBL11691842 | 0.78 | LMNA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707277-A1 | NOVEL HETEROCYCLIC AMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Daewoong Pharmaceutical Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024228580-A1 | NOVEL HETEROCYCLIC AMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 대웅제약 | 2024-11-07 | — | — | WO | disclosed |
| US-10370393-B2 | Stereoretentive cross-coupling of boronic acids | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180305381-A1 | STEREORETENTIVE CROSS-COUPLING OF BORONIC ACIDS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2018-10-25 | — | — | US | disclosed |
| WO-2010081149-A1 | ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | GLAXOSMITHKLINE LLC (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20080176912-A1 | GPR40 AGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-07-24 | — | — | US | disclosed |